Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MW

Matthew Weiss — 47 Patents

AMAmgen: 27 patents #59 of 2,867Top 3%
KTKymera Therapeutics: 18 patents #3 of 23Top 15%
TLTeijin Pharma Limited: 1 patents #114 of 294Top 40%
Watertown, MA: #9 of 1,634 inventorsTop 1%
Massachusetts: #1,375 of 88,656 inventorsTop 2%
Overall (All Time): #59,703 of 4,157,543Top 2%
47 Patents All Time
Matthew Weiss has been granted 47 US patents while listed as an inventor at Amgen. The first was granted in 2008 and the most recent in October 2025. Matthew Weiss ranks #59,703 of 4,157,543 US inventors in our database (top 1.4%). Patent records list Matthew Weiss in Watertown, MA, US.

Issued Patents All Time

Showing 1–25 of 47 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12454520 Protein degraders and uses thereof Yinze Zhang, Nan Ji, Arthur F. Kluge 2025-10-28
12258341 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Kluge, Yi Zhang, Xiaozhang Zheng 2025-03-25
12168057 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Kluge, Yi Zhang 2024-12-17
12150995 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Xiaozhang Zheng, Yi Zhang, Paul R. Fleming +1 more 2024-11-26
12091411 IRAK degraders and uses thereof Nello Mainolfi, Chris DE SAVI, Xiao Zhu, Xiaozhang Zheng, Bruce Follows 2024-09-17
11932624 MDM2 degraders and uses thereof Nan Ji, Xiaozhang Zheng, Xiao Zhu 2024-03-19
11897882 Tricyclic crbn ligands and uses thereof Nan Ji, Arthur F. Kluge, Yi Zhang 2024-02-13
11807636 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Kluge, Yi Zhang, Xiaozhang Zheng 2023-11-07 $12,552,000
11779578 IRAK degraders and uses thereof 2023-10-10 $11,091,000
11723980 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Kluge, Yi Zhang 2023-08-15 $17,110,000
11707457 IRAK degraders and uses thereof 2023-07-25 $20,136,000
11623932 Protein degraders and uses thereof Nello Mainolfi, Nan Ji, Yi Zhang 2023-04-11 $32,908,000
11591332 IRAK degraders and uses thereof Xiaozhang Zheng, Xiao Zhu 2023-02-28 $33,473,000
11358948 CRBN ligands and uses thereof Nello Mainolfi, Nan Ji, Yi Zhang 2022-06-14 $12,226,000
11352350 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Kluge, Yi Zhang, Xiaozhang Zheng 2022-06-07 $13,872,000
11332459 Benzimidazole derivatives and their uses Michael D. Bartberger, Nagasree Chakka, Hua Gao, Angel Guzman-Perez, Daniel B. Horne +9 more 2022-05-17
11318205 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Fluge, Yi Zhang 2022-05-03 $18,820,000
11292792 Tricyclic CRBN ligands and uses thereof Nan Ji, Arthur F. Kluge, Yi Zhang 2022-04-05 $31,937,000
11117889 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Kluge, Yi Zhang, Xiaozhang Zheng 2021-09-14 $63,228,000
10874743 IRAK degraders and uses thereof Nello Mainolfi, Nan Ji, Arthur F. Kluge, Yi Zhang 2020-12-29 $67,025,000
10729684 Alkynyl dihydroquinoline sulfonamide compounds Thomas A. Dineen, Karina R. VAIDA 2020-08-04 $893,024,000
10668067 Pyridine sulfonamides John R. BUTLER, Benjamin C. Milgram, Gwenaella Rescourio, Alessandro Boezio, Brian Andrew Sparling +1 more 2020-06-02 $385,167,000
10472356 Bicyclic ketone sulfonamide compounds Benjamin C. Milgram, Thomas A. Dineen, John Stellwagen, Angel Guzman-Perez, Alessandro Boezio +1 more 2019-11-12 $315,676,000
10383866 Alkyl dihydroquinoline sulfonamide compounds Thomas A. Dineen, Benjamin C. Milgram 2019-08-20 $585,693,000
9776995 Bicyclic sulfonamide compounds as sodium channel inhibitors Erin F. Dimauro, Thomas A. Dineen, Russell Graceffa, Angel Guzman-Perez, Hongbing Huang +5 more 2017-10-03 $315,293,000